Nelson memo

The Nelson Memo: Igniting a Global Open Data Revolution

The landscape of scientific research is undergoing a seismic shift, driven by an urgent demand for transparency, reproducibility, and equitable access. At the epicenter of this transformation in the United States is the Nelson Memo, a policy directive rapidly accelerating the future of open science. With the National Institutes of Health (NIH)'s recent announcement (NOT-OD-25-101)…...
Read More

Top Stories

MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Rare diseases

Rare Diseases – An Evolving Medical Communications Landscape

A disease is considered rare when it affects fewer than 1 in 2,000 people. However...
AI in Medical Affairs & Medical Communications

Science, AI, and Human Ingenuity Converge to Transform Medical Affairs

Today, we're witnessing an unprecedented convergence of scientific advancement, artificial intelligence (AI) capabilities, and human...
Digital Strategies for Medical Affairs

CyberThink in Action: 3 Digital Strategies for Medical Affairs

Everyone is talking about how Medical Affairs needs to evolve and innovate by being open-minded...

The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans

In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to Engage Medical Affairs

Engagement with Medical Affairs is critical at every juncture in the drug development process, with...
AI, ML, NLP, AR/VR, Blockchain in Healthcare

Emerging Technologies: Healthcare Communication Friend or Foe?

Embracing emerging technologies and innovations is not just an option but a necessity for biopharma...

Learn more ABOUT our company.